New York S 599: Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Status: SUBSTITUTED BY A1707A (as of 2023-06-06)

State: New York · Session: 2023-2024 · Bill: S 599

Sponsors: Julia Salazar, John Liu, Joseph P. Addabbo Jr., Rachel May, Robert Jackson

View New York S 599 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.